title: Bupropion and sexual function: a placebo-controlled prospective study on diabetic men with erectile dysfunction.
abstract: Many antidepressant agents interfere with sexual function. The purpose of this single-blind, prospective study was to determine sexual side effects, both positive and negative, of the amino-ketone antidepressant bupropion in a group of nondepressed diabetic men with somatic erectile dysfunction. Fourteen men participated in a 10-week protocol consisting sequentially of 2 weeks of baseline testing, 2 weeks of placebo, and 6 weeks of bupropion. Participants also completed daily and weekly questionnaires concerning sexual functioning, and a team of investigators rated various dimensions of sexual function every 2 weeks. In addition, a variety of physiologic measures, relevant either to erectile function or to neural/vascular systems that underlie sexual response, were assessed during baseline and bupropion treatment. Results indicated that neither subjective nor objective measures of erectile and overall sexual functioning worsened during bupropion. In fact, several measures suggested a trend toward improved sexual functioning. Furthermore, diabetic control was unaffected by bupropion administration. Given the lack of adverse effects on sexual function, along with the potential for improved erectile response, bupropion may provide an attractive choice for the treatment of depression in diabetic men or others for whom sexual dysfunction is a concern.
authors.affiliation: Department of Psychology, Valparaiso University, IN 46383, USA. DROWLAND@exodus.valpo.edu
authors.forename: D L
authors.initials: DL
authors.lastname: Rowland
authors.forename: L
authors.initials: L
authors.lastname: Myers
authors.forename: A
authors.initials: A
authors.lastname: Culver
authors.forename: J M
authors.initials: JM
authors.lastname: Davidson
mesh_terms: D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology*; D016642:Bupropion / Q000494:pharmacology*; D003925:Diabetic Angiopathies / Q000503:physiopathology*; D003929:Diabetic Neuropathies / Q000503:physiopathology*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D007172:Erectile Dysfunction / Q000503:physiopathology*; D006801:Humans; D018783:Impotence, Vasculogenic / Q000503:physiopathology*; D007989:Libido / Q000187:drug effects* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D010410:Penile Erection / Q000187:drug effects* / Q000502:physiology; D011446:Prospective Studies; D016037:Single-Blind Method
chemical_list: D018687:Antidepressive Agents, Second-Generation; D016642:Bupropion